That idea is ripped off from a Forbes article one month ago (http://www.forbes.com/sites/sciencebiz/2017/01/17/the-u-s-government-should-buy-gilead-for-156-billion-to-save-money-on-hepatitis-c/#528c6ad645b9 ).